Compare Packaging Corporation of America (PKG) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Tango Therapeutics Inc. — how do they compare? Packaging Corporation of America trades at $229.97 (market cap $20.49B), while Tango Therapeutics Inc. trades at $22.3 (market cap $3.74B). The key difference: Packaging Corporation of America is far larger — about 5.5× Tango Therapeutics Inc.'s market cap, and Packaging Corporation of America pays a 2.61% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 47 Days and Tango Therapeutics Inc. for 0 Days on average.
| PKG | TNGX | |
|---|---|---|
Market Cap | $20.49B | $3.74B |
Volume | 566,331 | 3,438,781 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $32.90 |
52-Week Low | $191.68 | $7.50 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $24.30B | $2.76B |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $231.65, up 1.68% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $2.35, beating estimates, though net income margin is projected to decline from 8.61% in 2025 to 7.25% in 2026. Recent news highlights institutional buying and upcoming Q3 earnings call on October 22, 2026.
PKG offers stable dividend income with a $1.50 quarterly payout, but faces margin pressure from rising costs. Analyst consensus is mixed with 34.62% buy ratings and a $272.43 price target suggesting 17.6% upside. Key risks include cost inflation and competitive pressures in the packaging sector.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
